Humana Inc. $HUM Holdings Trimmed by National Pension Service

National Pension Service cut its holdings in Humana Inc. (NYSE:HUMFree Report) by 3.5% during the 2nd quarter, Holdings Channel.com reports. The fund owned 178,391 shares of the insurance provider’s stock after selling 6,442 shares during the quarter. National Pension Service’s holdings in Humana were worth $70,860,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Wilkerson Advisory Group LLC grew its stake in shares of Humana by 24.6% in the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after purchasing an additional 33 shares during the last quarter. Cidel Asset Management Inc. lifted its stake in Humana by 1.1% during the second quarter. Cidel Asset Management Inc. now owns 3,883 shares of the insurance provider’s stock valued at $1,542,000 after purchasing an additional 41 shares during the last quarter. Bogart Wealth LLC lifted its stake in Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Fiduciary Alliance LLC boosted its holdings in Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after buying an additional 49 shares in the last quarter. Finally, Parkside Financial Bank & Trust grew its position in Humana by 20.0% in the second quarter. Parkside Financial Bank & Trust now owns 324 shares of the insurance provider’s stock worth $129,000 after buying an additional 54 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Performance

Shares of NYSE HUM opened at $408.79 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The business’s 50-day moving average price is $388.94 and its two-hundred day moving average price is $303.54. The company has a market capitalization of $49.09 billion, a P/E ratio of 38.67, a price-to-earnings-growth ratio of 2.48 and a beta of 0.74.

Humana (NYSE:HUMGet Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period last year, the business earned $6.27 EPS. Analysts anticipate that Humana Inc. will post 9 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, October 30th. Humana’s dividend payout ratio (DPR) is presently 33.49%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Zacks Research cut Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, August 14th. Leerink Partners upgraded Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price on the stock in a report on Thursday, July 30th. Mizuho boosted their target price on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, HSBC downgraded Humana to a “hold” rating in a report on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $403.91.

Get Our Latest Report on Humana

Humana Company Profile

(Free Report)

Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.

Featured Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.